Tender Details

Country: USA
Summary: Intent to Sole Source, Anavorx Distribution LLC, Anascorp Scorpion Antivenom, IHS, Colorado River Service Unit, Havasupai Health Center, Phoenix Indian Medical Center
UST Ref No: 123583248
Deadline: 08 Aug 2025
Financier: Self Financed
Purchaser Ownership: Government
Tender Value: Refer Document
Notice Type: Tender
Document Ref. No.: IHS1509028-PAO
Purchaser's Detail:
Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
Login to see details
Description:
Description
This is a notification of an intent to award three Delivery/Task Orders sole source contract to Anovorx Distribution LLC. under NAICS code 325412 - Pharmaceutical Preparation and Manufacturing for the Indian Health Services for a period of performance from July 25, 2025 to April 14, 2026 under the authority of FSS Limited Source Justification, Orders Against FSS, FAR FAR 8.405-6(a)(1)(i)(B)), Only One Source.
The Phoenix Area Pharmacy Consultant is requesting three Delivery/Task Order Sole Source Awards to Anovorx Distribution, LLC, distributor for Rare Disease Therapeutic Inc FSS #36F79718D0404, to provide Anascorp, Centroides (Scorpion) Immune F(ab-)2(Equine), Injection on a as needed basis from July 25, 2025 to April 14, 2026 for the clinics and hospitals under the Phoenix Area. Anovorx will provide a Anascorp Injection on a As Needed Basis.
Anovorx Distribution, LLC is the only contractor to offer ANASCORP [Centruroides (Scorpion) Immune F(ab-)2 (Equine) Injection] is an equine-derived antivenom indicated for treatment of patients with clinical signs of scorpion envenomation.
Anascorp is composed of venom-specific F(ab-)2 fragments of immunoglobulin G (IgG) that bind and neutralize venom toxins, facilitating redistribution away from target tissues and elimination from the body. Physician will initiate treatment with Anascorp Injection as soon as possible after scorpion sting in patients who develop clinically important signs of scorpion envenomation, including but not limited to loss of muscle control, roving or abnormal eye movements, slurred speech, respiratory distress, excessive salivation, frothing at the mouth and vomiting.
Anascrop Injection is widely used by the Southwest Regional Indian Health Services Hospitals and Clinics including Tucson Area, Albuquerque Area and Phoenix Area.
If you can provide the supplies requested, all responsible sources may submit a capability statement, which shall be considered by the Ag...
Documents:

If you are registered member, kindly login to view full details of this tender notice:

Intent to Sole Source, Anavorx Distribution LLC, Anascorp Scorpion Antivenom, IHS, Colorado River Service Unit, Havasupai Health Center, Phoenix Indian Medical Center - USA Tender

The HEALTH AND HUMAN SERVICES, DEPARTMENT OF | INDIAN HEALTH SERVICE, a Government sector organization in USA, has announced a new tender for Intent to Sole Source, Anavorx Distribution LLC, Anascorp Scorpion Antivenom, IHS, Colorado River Service Unit, Havasupai Health Center, Phoenix Indian Medical Center. This tender is published on USARFP under UST Ref No: 123583248 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-08-08.

The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.